ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Human Genome Project publishes its final product.

October 22, 2004

NCI Bypass Budget Published, Seeks $2.7 Billion In FY98

June 14, 1996

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974